MANAGED ASSET PORTFOLIOS, LLC - TAKEDA PHARMACEUTICAL CO LTD ownership

TAKEDA PHARMACEUTICAL CO LTD's ticker is TAK and the CUSIP is 874060205. A total of 294 filers reported holding TAKEDA PHARMACEUTICAL CO LTD in Q1 2023. The put-call ratio across all filers is 0.29 and the average weighting 0.1%.

Quarter-by-quarter ownership
MANAGED ASSET PORTFOLIOS, LLC ownership history of TAKEDA PHARMACEUTICAL CO LTD
ValueSharesWeighting
Q3 2023$26,862,356
-0.1%
1,736,416
+1.5%
4.12%
+2.0%
Q2 2023$26,881,782
+111018.5%
1,711,125
+16.6%
4.04%
+9.9%
Q1 2023$24,192
+5.5%
1,467,952
-0.1%
3.67%
+2.4%
Q4 2022$22,923
-99.9%
1,469,428
+0.5%
3.58%
+6.6%
Q3 2022$18,959,000
-6.5%
1,461,814
+1.2%
3.36%
+4.5%
Q2 2022$20,285,000
+1.2%
1,444,801
+3.2%
3.22%
+17.3%
Q1 2022$20,046,000
+26.1%
1,399,878
+20.1%
2.75%
+22.3%
Q4 2021$15,893,000
-20.2%
1,166,028
-4.1%
2.24%
-26.0%
Q3 2021$19,914,000
-1.9%
1,215,749
+0.8%
3.03%
+0.3%
Q2 2021$20,300,000
+4.3%
1,206,188
+13.2%
3.02%
-3.4%
Q1 2021$19,461,000
+10.6%
1,065,756
+10.3%
3.13%
+1.2%
Q4 2020$17,593,000
+8.1%
966,643
+6.0%
3.09%
-4.4%
Q3 2020$16,270,000
+55.3%
911,984
+56.1%
3.24%
+42.4%
Q2 2020$10,474,000
+123.1%
584,176
+88.9%
2.27%
+81.7%
Q1 2020$4,695,000309,2751.25%
Other shareholders
TAKEDA PHARMACEUTICAL CO LTD shareholders Q1 2023
NameSharesValueWeighting ↓
Adelphi Capital LLP 8,958,784$176,757,00033.75%
Ovata Capital Management Ltd 879,800$17,557,092,00013.04%
Paulson & Co. 13,244,711$261,318,0005.64%
Glenview Capital Management 30,582,721$603,397,0005.28%
MIC CAPITAL PARTNERS (PUBLIC) (US) IM, LLC 718,028$14,167,0004.85%
Velanne Asset Management Ltd 302,694$5,972,0003.52%
Blackcrane Capital, LLC 172,708$3,408,0002.72%
Melqart Asset Management (UK) Ltd 1,557,000$30,720,0002.57%
GMT CAPITAL CORP 3,345,976$66,016,0002.55%
REDWOOD CAPITAL MANAGEMENT, LLC 827,955$16,336,0002.24%
View complete list of TAKEDA PHARMACEUTICAL CO LTD shareholders